CME ArticlePregabalin A New Agent for Neuropathic PainGevirtz, Clifford MD, MPHAuthor Information Dr. Gevirtz is Clinical Associate Professor, Department of Anesthesiology, Louisiana State University-New Orleans, LA, and Medical Director, Somnia Pain Management, 627 West Street, Harrison, NY 10528; E-mail: [email protected]. Dr. Gevirtz has disclosed that he has no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity. He also has disclosed that the use of pregabalin for the treatment of fibromyalgia syndrome as discussed in this article has not been approved by the U.S. Food and Drug Administration. Wolters Kluwer Health has identified and resolved all faculty conflicts of interest regarding this educational activity. Topics in Pain Management: March 2006 - Volume 21 - Issue 8 - p 1-5 Buy CE Test Copyright © 2006 Wolters Kluwer Health, Inc. All rights reserved.